Katherine Rowe

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Jump to: navigation, search

Katherine (Kathy) Sylvia Rowe, MD, is a consultant paediatrician at the University of Melbourne Royal Children's Hospital, Victoria, Australia, and an expert in the area of ME/CFS and the relationship between health and education. She has learned much from her extensive cohort and feedback from the young people with this illness.

Boards and committees[edit | edit source]

Pediatric case definition[edit | edit source]

  • 2006, A Pediatric Case Definition for Myalgic Encephalomyelitis and Chronic Fatigue Syndrome[1] - (Full Text)

IOM Committee on Diagnostic Criteria for ME/CFS[edit | edit source]

  • Dr Rowe was a reviewer for the 2015 report produced by the Institute of Medicine's Committee on Diagnostic Criteria for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.[2]

2017 Pediatric Primer[edit | edit source]

Dr. Katherine Rowe was one of the authors of the 2017 Pediatric Primer published in Frontiers in Pediatrics.

ME/CFS Common Data Element (CDE) Project[edit | edit source]

Member of the Sleep Working Group and the Autonomic Working Group of the Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Common Data Element (CDE) Project sponsored by the National Institute of Neurological Disorders and Stroke and the Centers for Disease Control and Prevention.[4]

Talks and interviews[edit | edit source]

Research studies on ME/CFS[edit | edit source]

  • 1997, Double-blind randomized controlled trial to assess the efficacy of intravenous gammaglobulin for the management of chronic fatigue syndrome in adolescents[5] - (Abstract)
  • 1999, Five-Year Follow-Up of Young People with Chronic Fatigue Syndrome Following the Double Blind Randomised Controlled Intravenous Gammaglobulin Trial[6] - (Abstract)
  • 2009, Severe versus Moderate criteria for the new pediatric case definition for ME/CFS[7] - (Abstract)
  • 2019, Long term follow up of young people with Chronic Fatigue Syndrome attending a pediatric outpatient service[8] - (Abstract)
  • 2019, Epidemiology of paediatric chronic fatigue syndrome in Australia[9] - (Full text)
  • 2019, Resting-state functional connectivity, cognition, and fatigue in response to cognitive exertion: a novel study in adolescents with chronic fatigue syndrome[10] - (Abstract)

See also[edit | edit source]

References[edit | edit source]

  1. Jason, Leonard A; Jordan, Karen; Miike, Teruhisa; Bell, David S; Lapp, Charles; Torres-Harding, Susan; Rowe, Kathy; Gurwitt, Alan; De Meirleir, Kenny; Van Hoof, Elke LS (2006), "A Pediatric Case Definition for Myalgic Encephalomyelitis and Chronic Fatigue Syndrome", Journal of Chronic Fatigue Syndrome, 13 (2-3): 1-44, doi:10.1300/J092v13n02_01 
  2. https://www.nap.edu/resource/19012/MECFS_Powerpoint.pdf
  3. Rowe, Peter C.; Underhill, Rosemary A.; Friedman, Kenneth J.; Gurwitt, Alan; Medow, Marvin S.; Schwartz, Malcolm S.; Speight, Nigel; Stewart, Julian M.; Vallings, Rosamund; Rowe, Katherine S. (2017), "Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Diagnosis and Management in Young People: A Primer", Frontiers in Pediatrics, 5 (121), doi:10.3389/fped.2017.00121 
  4. "Complete Myalgic Encephalomyelitis/Chronic Fatigue Syndrome CDE Roster". NIH. Retrieved Oct 11, 2019. 
  5. Rowe, K.S. (1997), "Double-blind randomized controlled trial to assess the efficacy of intravenous gammaglobulin for the management of chronic fatigue syndrome in adolescents.", Journal of Psychiatric Research, 31 (1): 133-47, PMID 9201655 
  6. Rowe, K.S. (1999), "Five-Year Follow-Up of Young People with Chronic Fatigue Syndrome Following the Double Blind Randomised Controlled Intravenous Gammaglobulin Trial", Journal of Chronic Fatigue Syndrome, 5 (3-4): 97-107, doi:10.1300/J092v05n03_08 
  7. Jason, Leonard; Porter, Nicole; Shelleby, E; Till, L; Bell, David S; Lapp, Charles W; Rowe, Kathy; De Meirleir, Kenny (2009), "Severe versus Moderate criteria for the new pediatric case definition for ME/CFS", Child Psychiatry and Human Development, 40 (4): 609-20, doi:10.1007/s10578-009-0147-8 
  8. Rowe, Katherine S. (Jan 2019). "Long term follow up of young people with Chronic Fatigue Syndrome attending a pediatric outpatient service". Frontiers in Pediatrics. doi:10.3389/fped.2019.00021. 
  9. Knight, Sarah; Elders, Shane; Rodda, Jill; Harvey, Adrienne; Lubitz, Lionel; Rowe, Kathy; Reveley, Colette; Hennel, Sabine; Towns, Susan; Kozlowska, Kasia; Payne, Donald N; Marshall-Gradisnik, Sonya; Scheinberg, Adam (Feb 23, 2019). "Epidemiology of paediatric chronic fatigue syndrome in Australia". Archives of Disease in Childhood: archdischild–2018–316450. doi:10.1136/archdischild-2018-316450. ISSN 0003-9888. 
  10. Josev, Elisha K.; Malpas, Charles B.; Seal, Marc L.; Scheinberg, Adam; Lubitz, Lionel; Rowe, Kathy; Knight, Sarah J. (May 17, 2019). "Resting-state functional connectivity, cognition, and fatigue in response to cognitive exertion: a novel study in adolescents with chronic fatigue syndrome". Brain Imaging and Behavior. doi:10.1007/s11682-019-00119-2. ISSN 1931-7557. 

Myalgic encephalomyelitis (ME) - A disease often marked by neurological symptoms, but fatigue is sometimes a symptom as well. Some diagnostic criteria distinguish it from chronic fatigue syndrome, while other diagnostic criteria consider it to be a synonym for chronic fatigue syndrome. A defining characteristic of ME is post-exertional malaise (PEM), or post-exertional neuroimmune exhaustion (PENE), which is a notable exacerbation of symptoms brought on by small exertions. PEM can last for days or weeks. Symptoms can include cognitive impairments, muscle pain (myalgia), trouble remaining upright (orthostatic intolerance), sleep abnormalities, and gastro-intestinal impairments, among others. An estimated 25% of those suffering from ME are housebound or bedbound. The World Health Organization (WHO) classifies ME as a neurological disease.

ME/CFS - An acronym that combines myalgic encephalomyelitis with chronic fatigue syndrome. Sometimes they are combined because people have trouble distinguishing one from the other. Sometimes they are combined because people see them as synonyms of each other.

Randomized controlled trial (RCT) - A trial in which participants are randomly assigned to two groups, with one group receiving the treatment being studied and a control or comparison group receiving a sham treatment, placebo, or comparison treatment.

Cognition - Thought processes, including attention, reasoning, and memory.

The information provided at this site is not intended to diagnose or treat any illness.
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history.